Stock A1LN34 ALNYLAM PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Alnylam Pharmaceuticals, Inc. Sao Paulo

Equities

A1LN34

BRA1LNBDR003

Delayed Sao Paulo
Other stock markets
 20:15:55 02/07/2024 BST 		5-day change 1st Jan Change
70.3 BRL +4.07% Intraday chart for Alnylam Pharmaceuticals, Inc. +41.48% +57.45%
03:50pm Jerome Powell did it again Our Logo
12:55pm JPMorgan Chase Raises Price Target on Alnylam Pharmaceuticals to $248 From $160 MT

Insiders

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Alnylam Pharmaceuticals Insider Sold Shares Worth $370,747, According to a Recent SEC Filing
MT
Alnylam Pharmaceuticals Insider Sold Shares Worth $1,917,475, According to a Recent SEC Filing
MT
Alnylam Pharmaceuticals Insider Sold Shares Worth $485,773, According to a Recent SEC Filing
MT
Alnylam Pharmaceuticals Insider Sold Shares Worth $7,161,360, According to a Recent SEC Filing
MT
Alnylam Pharmaceuticals Insider Sold Shares Worth $3,224,546, According to a Recent SEC Filing
MT
Alnylam Pharmaceuticals Insider Sold Shares Worth $4,540,071, According to a Recent SEC Filing
MT
Alnylam Pharmaceuticals Insider Sold Shares Worth $455,357, According to a Recent SEC Filing
MT
Alnylam Pharmaceuticals Insider Sold Shares Worth $272,050, According to a Recent SEC Filing
MT
Alnylam Pharmaceuticals, Inc. Announces Transition of Indrani L. Franchini as Executive Vice President, Chief Legal Officer and Secretary, Effective on March 1, 2024
CI
Alnylam Pharmaceuticals Insider Sold Shares Worth $5,850,000, According to a Recent SEC Filing
MT
Marsha H. Fanucci Resigns from Board of Directors of Alnylam Pharmaceuticals, Inc
CI
Vistagen Therapeutics Hires Alnylam's Cindy Anderson to Become Finance Chief
MT
Insider Sell: Alnylam Pharmaceuticals
MT
Insider Sell: Alnylam Pharmaceuticals
MT
Alnylam Pharmaceuticals, Inc. Announces Management Changes, Effective October 2, 2023
CI
Insider Sell: Alnylam Pharmaceuticals
MT
Amylyx Pharmaceuticals Appoints Masako Nakamura to Head of International Markets, Asia Pacific and Latin America
CI
Insider Sell: Alnylam Pharmaceuticals
MT
Alnylam Pharmaceuticals, Inc. Appoints Peter Kellogg to Board of Directors
CI
Insider Sell: Alnylam Pharmaceuticals
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALNY Stock
  4. A1LN34 Stock
  5. News Alnylam Pharmaceuticals, Inc.
  6. Insiders